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ABSTRACT
The biological activity of eight 1-oxa-4-aza-2-silacyclanes with the OSiCH2N fragment
including 6-membered 2-sila-5-morpholinones (1-3) and 4-acyl-2-silamorpholines (4-6)and
previously unknown 7-membered derivatives of salicylic acid (7,8) was studied. Compounds 1
and 3-6 show the certain antihypoxic action. Compounds 2 (40 mg/kg), 4 (20 mg/kg), 6 (40
mg/kg), 7 (20 mg/kg)and 8 (40 mg/kg) reduce the physical serviceability of intact animals.
Compound 1 (20 mg/kg)influences the physical serviceability in a moderate-positive way on
the background of chlorophos-poisoning. Compounds 5-8 displayed protective properties
against chlorophos-poisoning at the LD0 dose and compounds 2, 4, 5, 7 at the LDoo dose.
Influence of compounds 1 and :2 on the emotional-research behavior of mice was studied.
Keywords: Organosilicon compounds, -oxa-4-aza-2-silacyclanes; Hypoxia-
physiopathology; Behavior, animal-drug-effects; Correctors of adaptational mechanisms;
Organophosphorous compounds poisoning.
INTRODUCTION
At present the pentacoordinated organosilicon compounds are the objects of intense
investigation because of their unique structures, possible role as the intermediates in S-Si
reactions and biological activity [1-3]. The increased reactivity of such compounds revealed
in the course of last years led to investigation of their synthetic applications [2]. In particular,
these compounds may be used as precursors for the organoheterosilacyclanes, for example,
1-oxa-4-aza-2-silacyclanes [4, 5].
Taking into account the known physiological significance of silicon and biological
activity of organosilicon derivatives (synthesis of glycosaminoglycanes, influence on the
calcium, magnesium and aluminium exchange and oxidation metabolism, combination of
psychotropic and vazoactive properties and membrane-stabilizing action [3]), it was
reasonable to investigate these compounds as the potential correctors of the adaptational
mechanisms.
The present article reports the biological activity of eight 1-oxa-4-aza-2-silacyclanes,
6-membered 2-sila-5-morpholinones (1-3) and 4-acyl-2-silamorpholines (4-6), and previously
unknown 7-membered derivatives of salicylic acid (7, 8)** containing the OSiCH2N fragment.
The derivatives of lactic, mandelic, pantoic, y-hydroxybutyric, isonicotinic, salicylic acids
and
2-aminoethanol were chosen due to their known ’pharmacophoric nature’.
MATERIALS AND METHODS
The IR specra of the compounds were recorded in thin layer and solutions in KBr cells
on a Specord IR-75 instrument. The H NMR spectra of solutions in CDCI3 were recorded on a
Varian XL-400 spectrometer at 400.0 MHz. The chemical shifts were measured using TMS as
internal reference.
For preliminary data on the biological activity of compounds 1 and 2 see [6].
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Synthesis ofsilacyclanes
The synthesis of 2-sila-5-morpholinones, 2,2,4,6-tetramethyl-2-sila-5-morpholinone (1),
2,2,4-trimethyl-6-phenyl-2-sila-5-morpholinone (2), 2,2,4-trimethyl-6-(2-trimethylsiloxy-1,1-
dimethylethyl)-2-sila-5-morpholinone (3) and 4-acyl-2-silamorpholines, 2,2-dimethyl-4-acetyl-2-sila-
morpholine (4), 2,2-dimethyl-4-isonicotinoil-2-silamorpholine (5), 2,2-dimethyl-4-(4-
trimethylsiloxybutyril)-2-silamorpholine (6) was described previously. The constants of compounds
used in biological experiments correspond to the reported values [5].
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Synthesis of 7-membered silacyclane 7 was carried out in comparison with Scheme 1 using
N-methylsalicylamide as initial compound. The amide was transfomed into monosilylated product 9
and then into bissilyl derivative 10 using common mutes. Reaction of the latter with
chloro(chloromethyl)dimethylsilane (CCMDMS) led to desired silacyclane 7o
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The formation of intermediate O- and N-silylmethylated products 11 and 12 in the course of
the reaction was detected by special experiments.
Silacyclane 8 was prepared by the reaction of N-monoethanolsalicylamide with
hexamethyldisilazane (HMDS) and subsequent treatment of resulting bissililated product 13 with
CCMDMS in the presence of triethylamine (Scheme 2).
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2,2,4-Trimethyl-1-oxa-4-aza-2-sila-[6,7]-benzocycloheptan-5-one (7).
a. O-TrimethylsilyI-N-methylsalicylamide (9). HMDS (188 ml, 0.9 mol) was added dropwise to
45 g (0.3 mol) of the N-methylamide of salicylic acid. The reaction mixture was refluxed under
vigorous stirring for 2 h. After removing the excess of HMDS in vacuo the residue was fractionated
and 58 g (95%) of the desired product (9) were obtained. B.p. 160-161C (10 mm Hg), nD
1.5150. IR spectrum (v, cm-) 1669 (C=O). NMR H spectrum (5, ppm, CDCI): 0.33 s (9H, MezSi),
2.94 d (3H, MEN), 6.2-6.7 m (4H, CsH4), 8.04 d (1H, NH). Anal. Calcd for CHTNOSi, %: C 59.13,
H 7.67. Found, %: C 59.31, H 7.56.
b. O,N-bis(trimethy/si/y/)-N-methy/sa/icy/amide (10). Trimethylchlomsilane (TMCS, 36.7 g,
0.34 tool) was added dropwise to a solution of 47 g (0.23 mol) of compound 9 and 52 ml (0.34 mol)
of triethylamine in 100 ml of diethyl ether. The reaction mixture was refluxed under vigorous stirring
for 3 h. The precipitated salt was filtered out, the solvent was removed in vacuo. After the
fractionation of the residue 50 g (78%) of compound 10 were obtained. B. p. 143-144C (10 mm
Hg), nD 1.5145. IR spectrum (v, cm-): 1636 (C=O). H NMR spectrum (5, ppm, CDCI): 0.35
broad (18H, MeSiO+MeSiN), 2.78 s (3H, MEN), 6.78-7.48 m (4H, CsH4). Anal. Calcd for
C4H2sNO2Si2, %: C 56.88, H 8.52. Found, %: C 57.21, H 8.18.
c. One-pot synthesis of silacyc/ane (7). The mixture of 10 g (36 mmol) of amide 10 and 3 g
(36 mmol) of CCMDMS was heated until the complete elimination of TMCS (64-66C, 9.2 ml,
100%). After the fractionation of the residue 6.9 g (86%) of silacyclane 7 were obtained. B. p. 178-
180C (7 mm Hg). IR spectrum (v, cm): 1624 (NCO). H NMR spectrum (5, ppm, CDCI): 0.38 s
(6H, MeSi), 2.89 s (2H, CH), 3.21 s (3H, MEN), 6.9-7.8 m (4H, CsH4). Anal. Calcd for
CHsNO2Si, %: C 59.69, H 6.38, Si 12.69. Found, %: C 59.24, H 6.90, Si 12.05. Mol. weigth
(cryoscopy, CsHs): Calcd 221.38; found 222.
d. Evidence for the intermediate (N--SO-chelated O-(dimethy/ch/orosi/y/methy)-N-methy/-
salicy/amide (11) and (O--SO-chelated O-trimethylsilyI-N-(dimethylchlorosilylmethyl)-N-methyl-
sa/icy/amide (12). CCMDMS (1.6 g, 11 mmol) was added dropwise to the solution of 2.25 (10
mmol) of amide 10 in 5 ml of diethyl ether. In 5 min the presence of an intense band of
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O-silylmethylated product (1669 cm-) along with the bands at 1636 and 1597 cm-
corresponding
to the compound 10 and the N-silylmethylated product 12, respectively, was detected in the IR
spectrum of the reaction mixture. Afterwards the quick decrease of the bands at 1669 and 1639
cm-
along with a moderate increase of the band at 1597 cm-
was observed. In 30 min only the
product of N-silylmethylation 12 was detected in the IR spectrum of the mixture. After the removal of
TMCS and ether in vacuo at room termperature 2.6 (79%) of the chloride 12 were obtained
(yellow oil). IR spectrum (v, cm)" 1597, 1500 (NCO). ’H NMR spectrum (5, ppm, CDCI): 0.26 s
(6H, Me2Si), 0.36 s (9H, OSiMe3), 2.99 s (3H, MEN), 3.04 s (2H, CH2), 6.8-7.7 m (4H, C6H).
22Dimethy-4(2-trimethysixyethy)1-xa-4aza2-$ia[67]-benzcycheptan-5-ne (8).
a. O, O’-Bis(trimethylsilyl)salicylmonoethanolamide (13). A mixture of ethyl salicylate (152 g, 1
mol) and monoethanolamine (61 g, 1 mol) was refluxed with removal of ethanol for 2 h. After
recrystallization of the residue from ethyl acetate 107.5 g (65%) of the monoethanolamide of
salicylic acid were obtained. IR spectrum (v, cm-): 1630, 1560 (NHCO). The latter was refluxed
with 150 ml of HMDS for 2 h. After the fractionation 58 g (54%) of compound 13 were obtained.
B.p. 172-174C (5 mm Hg), nD
2 1.4395. IR spectrum (v, cm): 1645, 1510 (NCO). H NMR
spectrum (5, ppm, CDCI3): 0.10 s (9H, MezSiO), 0.35 s (9H, Me3SiN), 3.55 dt (2H, NCH2, ZJHH 7.0
HZ, 7.0 Hz), 3.73 t (2H, OCH2, JHH 7.0 HZ), 6.8-8.2 m (4H, C6H4), 8.15 broad (1H, NH). Anal. Calcd
for CsH2NO3Si2, %: C 55.34, H 8.36. Found, %: C 54.93, H 8.12.
b. Silacyc/ane (8). CCMDMS (18 g, 0.13 mol) was added dropwise for 30 min to the solution
of 34 g (0.1 mol) of compound 13 and 14.5 g (0.13 mol) of triethanolamine in 150 ml benzene. The
mixture was refluxed for 3 h and allowed to stand overnight. The precipitate was filtered out, the
solvent was removed in vacuo. After the fractionation of the residue 23 g (72%) of silacyclane 8
were obtained. B. p. 166-167C (1 mm Hg), no
2 1.5110. IR spectrum (v, cm-): 1616 (C--O). H
NMR spectrum (5, ppm, CDCI) 0.09 s (9H, MezSi), 0.31 s (6H, Me2Si), 2.92 s (2H, NCH2Si), 3.68 t
(2H, NCH2, "JHH 7.0 HZ), 3.84 (2H, OCH2, JHH 7.0 HZ), 6.8-7.6 m (4H, C6H). Anal. Calcd for
CsH25NO3Si, %: C 55.68, H 7.79, Si 17.36. Found, %: C 55.77, H 7.69, Si 17.38.
Biological study
The experiments were carried out on white alley mice, hams, weight 16-24 g. All compounds
were injected as water emulsion in ’twin-80’ intraperitoneal in the given range of doses before an
hour to the beginning of the registration of parameters. The animals of control groups were injected
with adequate volumes of salt infusion. The quantity of animals in each group varied from 6 to 15.
For data processing the basic methods of parametrical and unparametrical statistics
(t-criterion Student, discriminant function analysis, cluster analysis, correlation analyses) were used.
Acute toxicity of compounds was defined by the express train-method of V. Prozomvsky [7].
Acute hypobaric hypoxia (AHBH) was simulated in the flowing hypobaric chamber
(absorber of carbon dioxide, the 30% solution of KOH at 18-22C) by ’raising’ of the animals on the
height of 11000 m with the average speed of 50 m/sec. The survival rate of animals and the time of
their death (reserve time) were estimated [8].
Acute immersion cooling (AIC) was simulated by compulsory navigation without loading in
ice water (3.5-4.0 C). The duration of life of the animals had been estimated until the clonic
spasms and characteristic ’pose of capuchin’ appeared.
Physical serviceability (PS) was estimated on duration of floating in water at 28-29 C with
a cargo. It was attached to the basis of a tail, equal to 5% from weight of a body [9].
The preventive maintenance of acute organophosphorus compounds poisoning
(OPhC). The compounds were injected an hour before the chlorophos poisoning (1% solution,
subcutaneosly in doses LDo and LDoo). The survival rate had being analyzed within a day.
Therapeutic effect of the compounds at an acute organophosphorus compounds
poisoning (OPhC). The compounds were injected an hour before the chlorophos poisoning (1%
solution; subcutaneosly in doses LDso and LDoo). The survival rate had being analyzed within a day.
The influence of compounds on individual behavior. The psychotmpic effects of the
compounds on individual rough-research behavior were studied on the model called ’an open field’.
The ’open field’ for mice was composed of a chamber by the size 40x40x40 sm, painted in white
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colour and closed by a transparent cover. The floor of the chamber was lined on squares 10x10 sm
with a round aperture (’mousehole’) with a diameter of 3 sm at the centre of each square. The
research was carried out at electrical illumination by a glow-lamp with capacity 100 W, located on
distance 1.5 rn from the center of the field.
Behavior of each animal was estimated individually. A mouse was placed in the left corner
of the chamber. The complete structure of behavior had being registered for 4 minutes. It included
the following elements: smelling, moving, movement on a place, condition in a rule sitting, looking in
’mousehole’, vertical rule (stance with an emphasis, vertical stance), grooming, freezing, and also
the number of defecations and micturitions. It is necessary to add that not only the expression of
elements of behavior was estimated but also the probabilities of transitions from one condition into
the other were estimated [13].
The influence of compounds on metabolism was described by us previously [6].
RESULTS AND DISCUSSION
Chemical Aspects
The general synthetic approach to 1-oxa-4-aza-2-silacyclanes consists of the next steps. The
initial compounds are the monosubstituted amides of carboxylic acids containing the additional
hydroxylic group at the acid radical or/and at the substituent at the N atom. On the first stage
(Schemes 1,2, reactions a) this group should be protected by the transformation into the
corresponding O-trimethylsilyl derivative. One of possible ways for the next stage is the reaction of
the latter with CCMDMS in the presence of a base (amination method) leading to the unstable
(OSi)-chelated products of N-chlorodimethylsilylmethylation which contain the pentacoordinated
silicon atom. The thermal decomposition of these compounds with the elimination of MezSiCI in the
course of fractionation gives the desired silacyclanes. By this method, the known 2-sila-5-
morpholinones 1-3, 4-acyl-2-silamorpholines 4-6 and the derivative of salicylic acid 8 (Scheme 2)
were prepared.
The higher yields of desired silacyclanes 1-6 and 8 may be obtained without the isolation of
unstable pentacoordinated organosilicon chlorides. The existence of such intermediate compounds
was detected by the IR and NMR monitoring [5]. IR specra of impure chlorides show two bands at
1600-1605 and 1515-1520 cm-
of chelate C()NCH2;i fragment [10]. Intramolecular interaction
O-Si in these compounds was also confirmed by the upfield shift of signals in the Si NMR
spectra (up to-30 /-40 ppm), which testifies to the presence of pentacoordinated silicon atom
[, ].
Another way includes the transformation of the O-silylated product 9 under rather drastic
conditions into the corresponding bis-O,N-trimethylsilylmethylated product 10 (Scheme 1, reaction
b) following by the reaction with CCMDMS (reaction c, transsi/y/ation method).
The formation of intermediate O-silylmethylated product 11 and its subsequent isomerization
into the N-silylmethylated product 1:2 (reactions c, d) were confirmed by the IR specmscopy.
The general scheme of the reactions of trimethylsilyl derivatives of amides and lactams with
CCMDMS includes the intermediate product of transsilylation [12]. However, in the case of
bis-O,N-trimethylsilyl derivative 10 the corresponding product of could not be detected by the IR
spectroscopy and so it was excluded from scheme 1.
Pharmacology
The definition of acute toxicity of silacyclanes 1-8 on the first investigation phase revealed
their low toxicity (LDo 400-500 mg/kg) [14] and allowed to choose the acceptable doses for the
following experiments. Futher the doses equal 1140-1110 LDo (10, 20, 40 mg/kg) were used.
The study of antihypoxic activity of silacyclanes 1-8 (Table I) showed that compounds 1 (20
mg/kg), 3 (40 mg/kg), 4 (20 mg/kg), 5 (20 mg/kg) and 6 (20 mg/kg) increase the time of life of mice
in AHBH condition with different efficiency. Compounds in doses of 10 mg/kg did not affect the time
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of life. The analysis of experimental results allows to assume the presence of certain antihypoxic
activity of compounds 1, 3-6. The observed antihypoxic effects are comparable with the effects of
(2-oxo-l-pyrrolidinyl)acetamide (nootropil) or sodium 7-hydroxybutanoate in effective doses [8].
Compounds 7 and 8 showed no antihypoxic activity.
Silacyclanes 2 (40 mg/kg), 4 (20 mg/kg), 6 (40 mg/kg), 7 (20 mg/kg) and 8 (40 mg/kg) reduce
the PS while compounds 1 (20 mg/kg), 3 (40 mg/kg) and 5 (20 mg/kg) do not affect it.
The effects of compounds 1 and 2 were investigated using the model of acute immersion
cooling. They showed no influence on resistance of mice to AIC (see Table I).
The influence of silacyclanes 1-8 on PS of mice in natatory test with a cargo was
investigated on the background of chlorophos poisoning (0.5 LDs0). The duration of natatory was
increased after injection of compound 1 (20 mg/kg). Compounds 2 (40 mg/kg), 3 (40 mg/kg), 4 (20
mg/kg) and 5 (20 mg/kg) did not influence on it while the compounds 6 (20 mg/kg), 7 (20 mg/kg)
and 8 (40 mg/kg) reduced this parameter (Table I).
It is known that the adaptation of organism to AHBH and OPhC compound poisoning has
common mechanism [15]. Therefore, the combination in system screening of models AIC and
OPhC poisoning was of interest as a confirmation of direct correlation between frigoprotective
properties of compounds and their influence on PS. Besides, it was necessary to expect the return
dependence between antihypoxic activity and stimulating action (on the AHBH and OPhC model),
and also the OPhC-protective action and stimulating action.
The results of study OPhC-protective properties of silacyclanes 1-8 are summarized in Table
II. At chlorophos-poisoning in a dose LDo protective properties were displayed by compounds 5-8;
at a dose LDoo by compounds 2, 4, 5, 7.
Table II. A preventive effect of the compounds on dynamics survival rate of animals within a day
after the injection of chlorophos (LDso or LDoo).
Compound Dose Suwival within a day (min)
mg/kg 10 20 30 40 50 60 24 houm
chlomphos LD5o 8/8 818 518 218 218 218 218
1 20 6 6 4 2 2 2 2
2 40 6 5 2 2 2 2 2
3 40 6 6 6 4 4 4 0
4 20 6 6 5 2 2 2 2
5 20 6 6 5 5 5 5 5
6 20 6 6 5 3 3 3 3
7 20 6 6 4 4 4 4 4
8 40 6 6 6 5 5 5 5
chlomphos LD 8/8 4/8 0/8 018 018 0/8 8
1 20 6 6 4 1 1 1 1
2 40 6 5 3 2/6 2 2 2
3 20 6 3 3 1 1 1 1
4 20 6 6 5 5 4 4 4
5 20 6 6 5 2 2 2 2
6 40 6 6 0 0/6 0 0 0
7 20 6 6 3 2 2 2 2
8 40 6 6 4 1 1 1 1
In order to reveal an ethological effect of the compounds and to define the most important
parameters the profound screening of compounds 1 and 2 was carried out using the ’open field’
technique. Behavioral patterns and their communications were registered (Table III, Fig. 1).
It was found that 2-sila-5-morpholinones 1 and 2 do not render the expressed negative action
on the spectrum of individual behavior.
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Table III. The influence of compounds I and 2 on elements of behavior in ’open field’.
Elements of Expression of elements of behavior, sec
behavior Control, 1, 2,
n 10 n = 10 n 10
Smelling 97.6_+4.2 103.7_+2.9 A 98.1_+7.2
Moving 35.3_+7.4 34.3_+6 34.6+_11.2
Sitting 27.4-+9 27.5_+8.4 26.2+_10.6
Looking in "mousehole" 51.9+_2.2 45.4+_4.7 V 31.0_+5.1 VV
Movement on a place 16.0_+3.3 16.2___2.0 20.9+_2.6 A
Grooming 8.1___3.6 7.4___2.6 V 5.5+_2.2 V
Stance with an emphasis 4.3+_1.4 3.2+_1.1 V 0.0+_0 VV
Vertical stance 1.4+_0.5 0.3+_0.2 VV 2.6___1.2 A
Freezing 0.00-+0 1.9-+1.9 A 27.4-+14.5 A
Defecations 0.9_+0.2 1.1_+0.5 0.6_+0.3
Micturitions 0.00_0 0.00+_0 0.00_0
the parameter is increased;
authentically
the parameter decreases; VV the parameter decreases
Abbreviations
Sm smelling
M moving
St sitting
Lmh looking in the ’mousehole’
G grooming
Mp movement on a place
Se stance with an emphasis
p>0.5
0.3<p<0.5
"-- 0.1<p<0.3
Se
o
Sm
Control group
Mp
Sm
G
Sm
Lmh
G
Mp
Fig. 1. Graph-structure of the mice behavior in "open field" in an hour after the introduction of
compounds 1 and 2. Circles are the behavioral patterns (the diameter corresponds to the degree of
expression), arrows show the probability of transitions of behavior elements (the thickness
corresponds to statistical meanings of the probability).
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At the same time, the discriminant function analysis and the cluster analysis showed
that compounds 1 and 2 are different to each other and to the control in influence on the
structure of behavior. The parameters of emotional-research behavior of animals (stance with
an emphasis, vertical stance, grooming, looking in ’mousehole’) are the differentiating
attributes (general probability of distinction is 0.8). It is considered as sedative-tranquilizing
action which is useful at various kinds of stress and extreme influences.
The study of 1-oxa-4-aza-2-silacyclanes proved them to be perspective objects for the
investigation of means with psychotropic activity, directed on preventive maintenance stress
prevention, and also with the properties of metabolic proof-readers of hypoxia, i.e. the
compounds with actoprotective activity. It was demonstrated on a limited quantity of
biological material within the framework of the submitted system screening.
This work was supported by INTAS (Project No. 93-1411) and the Russian Foundation
for Basic Research (Project No. 96-03-32718).
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